Evidence map›Paper›PMID 30859482›Full record

ArticleJournal of neuro-oncology2019

Correction to: Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016.

Paloma Compes, Emeline Tabouret, Amandine Etcheverry, Carole Colin, Romain Appay, Nicolas Cordier, Jean Mosser, Olivier Chinot, Hervé Delingette, Nadine Girard and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Paloma CompesAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France.
Emeline TabouretAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France.ORCID http://orcid.org/0000-0002-4031-2178
Amandine EtcheverryIntegrated Functional Genomics and Biomarkers Team, UMR6290, CNRS, Université de Rennes 1, Rennes, France.
Carole ColinAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France.
Romain AppayAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France.
Nicolas CordierUniversité Côte d'Azur and Inria Sophia-Antipolis Méditerranée Asclepios Team, Inria Sophia Antipolis, Sophia Antipolis, France.
Jean MosserIntegrated Functional Genomics and Biomarkers Team, UMR6290, CNRS, Université de Rennes 1, Rennes, France.
Olivier ChinotAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France.
Hervé DelingetteUniversité Côte d'Azur and Inria Sophia-Antipolis Méditerranée Asclepios Team, Inria Sophia Antipolis, Sophia Antipolis, France.
Nadine GirardAix Marseille University UMR CNRS 7339, APHM Timone Hospital, Marseille, France.
Henry DufourAP-HM, Hôpital de la Timone, Service de Neurochirurgie, Marseille, France.
Philippe MetellusAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France.
Dominique Figarella-BrangerAix-Marseille Univ, CNRS UMR 7051, INP, Inst Neurophysiopathol, Marseille, France. dominique.figarella-branger@univ-amu.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the initial, online publication, the authors' given names were captured as family names and vice versa. The names are correctly shown here. The original article has been corrected.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.